NCT02894177

Brief Summary

Difficult weaning from ventilation and extubation failure are major issues in intensive care, concerning 30% and 12% of patients respectively. These can be partly explained by the lack of accuracy of spontaneous breathing trial (SBT) failure criteria to predict extubation failure. The investigators performed a pilot study to evaluate transcutaneous carbon dioxide pressure (tcPCO2) monitoring during SBTs. The results showed that the difference between maximum and initial tcPCO2 (or ΔtcPCO2) was significantly higher in the group of patients who failed SBTs according to the usual criteria. Moreover, the results suggested that ΔtcPCO2 could be an accurate and early criterion for SBT failure. The size of the study could not examine ΔtcPCO2 regarding extubation failure. Therefore, the main objective of this study is to determine if Δ tcPCO2 during SBTs is associated with extubation failure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2016

Completed
26 days until next milestone

First Posted

Study publicly available on registry

September 9, 2016

Completed
12 months until next milestone

Study Start

First participant enrolled

September 4, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
Last Updated

October 17, 2023

Status Verified

October 1, 2023

Enrollment Period

2.6 years

First QC Date

August 14, 2016

Last Update Submit

October 16, 2023

Conditions

Keywords

E02.880.820.950

Outcome Measures

Primary Outcomes (1)

  • Difference between maximum and initial tcPCO2 (ΔtcPCO2) during SBTs in patients who fail extubation compared to patients who have been successfully extubated.

    Extubation failure: need for reintubation, rescue non invasive ventilation or death within 7 days following extubation

    7 days

Secondary Outcomes (6)

  • Association between ΔtcPCO2 and extubation failure after adjustment on post extubation ventilation protocols (preventive non invasive ventilation or preventive Optiflow)

    7 days

  • Association between extubation decisions and ΔtcPCO2.

    1 week

  • Adverse Events associated with tcPCO2 monitoring.

    1 week

  • Optimal ΔtcPCO2 threshold to predict extubation failure by a ROC curve.

    7 days

  • Compare ROC curves obtained by different extubation failure predictors

    7 days

  • +1 more secondary outcomes

Study Arms (1)

tcPCO2 measurement arm

EXPERIMENTAL

Patients will be monitored by tcPCO2 during spontaneous breathing trials

Procedure: tcPCO2 measurement

Interventions

tcPCO2 continuous monitoring during spontaneous breathing trials

tcPCO2 measurement arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years old,
  • ICU indicated
  • invasive mechanical ventilation via orotracheal or nasotracheal intubation
  • presence of criteria for initiation of the weaning process as stated on our ICU's protocol
  • resolution of the disease leading to mechanical ventilation

You may not qualify if:

  • mechanical ventilation during less than 24 hours
  • Tracheotomy and tracheostomy at ICU admission
  • Pregnancy
  • Patient under legal protection
  • Patient enrolled in another study regarding weaning or CO2 metabolism

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CH Versailles

Le Chesnay, 78150, France

Location

Study Officials

  • Henao-Brasseur Juliana

    CH Versailles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Care providers will be blinded of tcPCO2 measurements to avoid influencing extubation decisions.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: tcPCO2 will be monitored in all patients performing SBTs. The difference between maximal and initial tcPCO2 (ΔtcPCO2) in patients succeeding extubation will be compared with ΔtcPCO2 in patients failing extubation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
study coordinator

Study Record Dates

First Submitted

August 14, 2016

First Posted

September 9, 2016

Study Start

September 4, 2017

Primary Completion

April 2, 2020

Study Completion

August 31, 2020

Last Updated

October 17, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations